A Prospective, Multicentre, Single Arm Clinical Study to Evaluate the Effect of Saroglitazar on Non High-Density Lipoprotein Cholesterol in Patients With Diabetic Dyslipidemia Inadequately Controlled With Diet, Exercise, and Statin-The GLIDDER Study

doi 10.35248/2155-6156.19.10.819
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Longdom Group

Related search

Effect of Tomato Consumption on High-Density Lipoprotein Cholesterol Level: A Randomized, Single-Blinded, Controlled Clinical Trial

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal MedicinePharmacology
2013English

The Effect of a Low-Fat, High-Carbohydrate Diet on Serum High Density Lipoprotein Cholesterol and Triglyceride

European Journal of Clinical Nutrition
MedicineNutritionDietetics
1998English

A Multicenter, Prospective, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 Mg Compared to Pioglitazone 45 Mg in Diabetic Dyslipidemia (PRESS V)

Journal of diabetes science and technology
Internal MedicineEndocrinologyBioengineeringBiomedical EngineeringMetabolismDiabetes
2014English

Atorvastatin Versus Rosuvastatin in Non-Diabetic Patients With Dyslipidemia: A Comparative Study

International Journal of Basic and Clinical Pharmacology
2016English

Distribution and Correlates of Non-High-Density Lipoprotein Cholesterol in Children: The Bogalusa Heart Study

Pediatrics
Child HealthPediatricsPerinatology
2002English

Trial Design of Phase IIIb, Open-Label, Single Arm Study to Evaluate Efficacy and Safety of Pasireotide LAR in Patients With Inadequately-Controlled Acromegaly Despite Treatment With First-Generation Somatostatin Analogues

Endocrine Abstracts
2015English

The Effect of Omalizumab in Mastocytosis Patients. Prospective Double-Blind, Placebo-Controlled Multicentre Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Association of Total Cholesterol, Low-Density Lipoprotein Cholesterol, and Non-High-Density Lipoprotein Cholesterol With Atherosclerotic Cardiovascular Disease and Cancer in a Chinese Male Population

International Journal of Cancer
Cancer ResearchOncology
2017English

The Effect of Aggressive Versus Standard Lipid Lowering by Atorvastatin on Diabetic Dyslipidemia: The DALI Study: A Double-Blind, Randomized, Placebo-Controlled Trial in Patients With Type 2 Diabetes and Diabetic Dyslipidemia

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy